Kuancan Liu

1.5k total citations
29 papers, 998 citations indexed

About

Kuancan Liu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Kuancan Liu has authored 29 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Kuancan Liu's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cancer Cells and Metastasis (5 papers). Kuancan Liu is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Cancer Cells and Metastasis (5 papers). Kuancan Liu collaborates with scholars based in China, United States and Hong Kong. Kuancan Liu's co-authors include Xiaopeng Lan, Jianwen Que, Baoshun Lin, Meng Zhao, Min Chen, Fei Liu, Xiangyue Yang, Tingting Zhao, Yunyun Chen and Rui Zhang and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Chemical Communications.

In The Last Decade

Kuancan Liu

27 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuancan Liu China 14 633 261 211 210 118 29 998
Véronique Giroux Canada 14 405 0.6× 287 1.1× 166 0.8× 265 1.3× 131 1.1× 23 834
Damiano Fantini United States 17 871 1.4× 275 1.1× 173 0.8× 238 1.1× 118 1.0× 27 1.2k
Pedram Kharaziha Sweden 14 795 1.3× 201 0.8× 427 2.0× 240 1.1× 104 0.9× 25 1.4k
Lucie Chambonnier France 15 395 0.6× 307 1.2× 176 0.8× 258 1.2× 121 1.0× 15 822
Tatsunori Suzuki Japan 17 373 0.6× 317 1.2× 215 1.0× 188 0.9× 117 1.0× 65 912
Jin‐Sook Jeong South Korea 20 583 0.9× 212 0.8× 202 1.0× 107 0.5× 81 0.7× 57 1.0k
Mark T. Boyd United Kingdom 21 710 1.1× 562 2.2× 281 1.3× 158 0.8× 162 1.4× 36 1.2k
Yong Hoon South Korea 16 574 0.9× 129 0.5× 284 1.3× 146 0.7× 63 0.5× 24 885
Aifa Tang China 18 647 1.0× 136 0.5× 423 2.0× 120 0.6× 92 0.8× 50 988
Guoqing Ru China 17 463 0.7× 272 1.0× 262 1.2× 70 0.3× 232 2.0× 70 941

Countries citing papers authored by Kuancan Liu

Since Specialization
Citations

This map shows the geographic impact of Kuancan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuancan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuancan Liu more than expected).

Fields of papers citing papers by Kuancan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuancan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuancan Liu. The network helps show where Kuancan Liu may publish in the future.

Co-authorship network of co-authors of Kuancan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kuancan Liu. A scholar is included among the top collaborators of Kuancan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuancan Liu. Kuancan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Xinxin, Zhuo Wang, Yongpan Liu, et al.. (2025). The advancements in organoids: Potential and challenges in researching the esophagus and esophageal squamous cell carcinoma. Genes & Diseases. 13(2). 101680–101680.
3.
Chen, Yunyun, Kun Zhang, Rui Zhang, et al.. (2023). Targeting the SOX2/CDP protein complex with a peptide suppresses the malignant progression of esophageal squamous cell carcinoma. Cell Death Discovery. 9(1). 399–399. 3 indexed citations
4.
Zhang, Jiaying, Zhuo Wang, Hongzhou Zhao, et al.. (2023). The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy. Biomedicine & Pharmacotherapy. 163. 114764–114764. 7 indexed citations
5.
Xue, Ding, Donghui Xu, Shuang Li, et al.. (2023). NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-β2. Cell Death and Disease. 14(8). 575–575. 14 indexed citations
6.
Zhang, Shihui, Yunyun Chen, Qiong Hu, et al.. (2022). SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p. Cancer Biology & Therapy. 23(1). 1–15. 10 indexed citations
7.
Wang, Zhuo, Tingting Zhao, Shihui Zhang, et al.. (2021). The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy. Biomarker Research. 9(1). 68–68. 40 indexed citations
8.
Zhao, Meng, Weibin Li, Kuancan Liu, Huiling Li, & Xiaopeng Lan. (2019). C4-HSL aptamers for blocking qurom sensing and inhibiting biofilm formation in Pseudomonas aeruginosa and its structure prediction and analysis. PLoS ONE. 14(2). e0212041–e0212041. 16 indexed citations
9.
Yan, Huihui, Kaiyu Wang, Qiang Wang, et al.. (2019). Development of a novel ssDNA aptamer targeting neutrophil gelatinase-associated lipocalin and its application in clinical trials. Journal of Translational Medicine. 17(1). 204–204. 7 indexed citations
10.
Lin, Sijie, Kuancan Liu, Yongchun Zhang, et al.. (2018). Pharmacological targeting of p38 MAP-Kinase 6 (MAP2K6) inhibits the growth of esophageal adenocarcinoma. Cellular Signalling. 51. 222–232. 23 indexed citations
11.
Liu, Kuancan, Rui Zhang, Long Zhang, et al.. (2017). SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis. Molecular Cancer. 16(1). 62–62. 85 indexed citations
12.
Lin, Baoshun, et al.. (2017). Basal progenitor cells bridge the development, malignant cancers, and multiple diseases of esophagus. Journal of Cellular Physiology. 233(5). 3855–3866. 3 indexed citations
13.
Zhang, Yongchun, Ming Jiang, Eugene S. Kim, et al.. (2016). Development and stem cells of the esophagus. Seminars in Cell and Developmental Biology. 66. 25–35. 58 indexed citations
14.
Lin, Baoshun, Rui Zhang, Hongyu Ma, et al.. (2015). Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A. Medicine. 94(31). e1301–e1301. 11 indexed citations
15.
Jiang, Ming, Zhongren Zhou, Evan S. Dellon, et al.. (2015). BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis. Journal of Clinical Investigation. 125(4). 1557–1568. 81 indexed citations
16.
Liu, Kuancan, Baoshun Lin, Hongyu Ma, et al.. (2014). Integrase-Deficient Lentivirus: Opportunities and Challenges for Human Gene Therapy. Current Gene Therapy. 14(5). 352–364. 20 indexed citations
17.
Liu, Kuancan, Baoshun Lin, Meng Zhao, et al.. (2013). The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cellular Signalling. 25(5). 1264–1271. 217 indexed citations
18.
Liu, Kuancan, Ming Jiang, Yun Lu, et al.. (2013). Sox2 Cooperates with Inflammation-Mediated Stat3 Activation in the Malignant Transformation of Foregut Basal Progenitor Cells. Cell stem cell. 12(3). 304–315. 154 indexed citations
19.
Liu, Kuancan, Baoshun Lin, Meng Zhao, Kaiyu Wang, & Xiaopeng Lan. (2012). Cutl1: A potential target for cancer therapy. Cellular Signalling. 25(1). 349–354. 12 indexed citations
20.
Liu, Kuancan, Baoshun Lin, & Xiaopeng Lan. (2012). Aptamers: A promising tool for cancer imaging, diagnosis, and therapy. Journal of Cellular Biochemistry. 114(2). 250–255. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Giroux Breakdown of academic impact, for papers by Damiano Fantini Breakdown of academic impact, for papers by Pedram Kharaziha Breakdown of academic impact, for papers by Lucie Chambonnier Breakdown of academic impact, for papers by Tatsunori Suzuki Breakdown of academic impact, for papers by Jin‐Sook Jeong Breakdown of academic impact, for papers by Mark T. Boyd Breakdown of academic impact, for papers by Yong Hoon Breakdown of academic impact, for papers by Aifa Tang Breakdown of academic impact, for papers by Guoqing Ru
Rankless by CCL
2026